Name
C.V. of Dr. Mohammed Ali Mohammed Ali
Mohammed Ali Mohammed
‫محمد علي محمد‬
Address
8 Hadad st., El Shatbi, - Alex- ‫ شارع الحداد –متفرع من شارع بور سعيد –الشاطبى‬8
‫األسكندريه‬
Birth
date
of 5/6/1964
‫تاريخ الميالد‬
Tel.
Email
Marital
status
+203 4961880, 01120731820
[email protected]
Married, has two children
‫متزوج ولديه طفالن‬
‫الحالة اإلجتماعية‬
Military
services
‫الخدمة العسكرية‬
Performed
‫أدي الخدمة العسكرية‬
Education
‫الدرجات العلمية‬
Positions
‫المناصب العلمية‬

Ph.D Medical Biochemistry 1996 Cairo University.
1996 ‫دكتوراه الكيمياء الحيويه الطبيه – المعھد القومى لألورام – جامعة القاھرة‬
1988 – 1992 …...Demonstrator of Biochemistry, National Cancer Institute,
Cairo university.
.‫ جامعة القاھرة‬, ‫ المعھد القومي لألورام‬, ‫ معيد الكيمياء الحيوية‬1992 – 1988
1992 – 1996 ……Ass. Lecturer of Biochemistry, National Cancer Institute,
Cairo University.
.‫ جامعة القاھرة‬, ‫ المعھد القومي لألورام‬, ‫ مدرس مساعد الكيمياء الحيويةالطبيه‬1996 – 1992
1996 – 2001 Lecturer of Biochemistry, National Cancer Institute, Cairo
University.
.‫ جامعة القاھرة‬, ‫ المعھد القومي لألورام‬, ‫ مدرس الكيمياء الحيوية الطبيه‬2001 – 1996
2001 -2006….Ass. Professor of Biochemistry & Molecular Biology, National
Cancer Institute, Cairo University.
‫ المعھد القومي‬, ‫استاذ مساعد الكيمياء الحيوية الطبيه والبيولوجيا الجزيئية‬2006– 2001
.‫ جامعة القاھرة‬, ‫لألورام‬
2006 to now…..Professor of molecular biology and medical Biochemistry ,National
Cancer Institute, Cairo University.
‫ جامعة القاھرة‬,‫المعھد القومى لألورام‬,‫ حتى األن استاذ للكيمياء الحيوية الطبية و البيولوجيا الجزيئية‬2006
2010 ( May – August )….Visitor Prof. Epindorff Faculty of Medicine , Hamburg
university, Germany .
2010 ( October – until now )…..Prof. and coordinator of Biochemistry, Faculty of
pharmacy, Gizan university.
Publications:
1-Mohammad Ali, Saad El Gendy and Abdel Hady Ali. Expressed Nacetyltransferase as a possible new prognostic marker for bladder and breast
cancer.Cancer Mlecular Biology,6(2):1291-1301,1999.
2-Sherif Y.Saad and Mohammad Ali. Effect of Taxol on the expression of
transforming growth factor beta-1 in Ehrlich Ascities Carcinoma cells. Saudi
pharmaceutical journal,7(2).1999.
3-Motawa El Houseini, Saad el Gendy, Mohammad Ali, Huussein Ismail, Abd El
Naser Hamad and Nader Dahaba.Evaluation of basic fibroblast growth factor and
matrix metalloproteinase in breast and bladder cancer patients.Bull.Egypt Soc.
Physiol. Sci,19(2),1999.
4-Mohammad Ali, Abdel Hady,Wael Yassien and Nadia Zakhary. Matrix
metalloproteinase-9 and tissue inhibitor marrix metalloprpteinase-2: A prognostic
indicator for metastatic bladder cancer. Cancer molecular Biology,7(1),14331443,2000.
Published as poster in the International Conference On Mechanisms of
Antimutagenesis &Anticarcinogenesis. Mitchigan.USA,2000.
5-Abdel Hady Ali and Mohammad Ali.Homozygous deletion of P16 gene in bladder
carcinoma in Egyptian Patients. J. Egyptian National Cancer Institute,12(1):2328.2000.
Third Pan Arab Cancer Congress ‫فاز ھذا البحث بالجائزة األولى كافضل بحث فى‬
6-Abdel Moneim Osman,Mohammad Ali, Abdel Hady Ali,and Mhammad Sayed.
Modulation by Verapamil of Doxorubcin induced expression of multidrug ressistance
gene (MDR)in Murine tumor cells .J. Egyptian National Cancer Institute,12(3):22112227,2000.
7-Mohammad Ali and Moustafa El Kabani. Relatio between p53/WAF 1 expression
to clinicopathological features of Egyptian breast cancer patients.Cancer Molecular
Biology,8:1613-1624,2001.
8-Mohammad Ali,Saad El Gendy, Hussein Ismail, Abdel Naser Hammad and Nader
Dahaba. Expression of TGF-1 and MMP2,9 activties in patients with hepatocellular
carcinoma.The Egyptian Society of Clinical Chemistry Serving
LaboratoryScience,27:303-312,2001.
9-Mostafa El Awady,Mohammad Ali, Wafaa Shousha,El Sayed El Mahdy and Marwa
Khalil. Potentially modulated genes in bladder cancer.Cncer Molecular
Biology,10:1909-1922,2003.
Published as poster in EACR 2004, Insbrruk, Ausria.
10-Wael Yassin, Mohammad Ali,Abdel Hady Ali, Zeinb El Daardery and Sabry
Sharawy.The P53/WAF1 dependent pathway in squamous cell carcinoma of bladder
associated with Bilharziasis. The medical Journal of Cairo University ,71(4):201209,2003.
11-Mohammad Sayed and Mohammad Ali. Contribution of Nitric Oxide and
Epidermal growth factor receptor in anti metastatic potential of Paclitaxol in human
liver cancer cell(HebG2).J. Of The Egyptian Natinal Cancer Institute,17(!):3540.2005.
12-Mohammad Ali , Saad El Gendy, Abdel Baset El AAser and Sabry Sharawy.Nitric
Oxide, matrix metalloproteinases(2,9) and tissue inhibitor matrix metalloprpteinase-1
levels in hepatocellular carcinoma of Egyptian patients. The Medical Journal Of Cairo
University,73(1):119-123,2005.
13-Mohammad Ali and Gehan Abdel Wahab. Association between
matrixmetalloproteinase2, membrane type 1 –matrix metalloproteinase and
hepatocyte growth factor inbreast cancer patients.The Egyptian Society
ofHaematology and Research,2(2):179-186,2006.
14-Mohammad Ali, Abdel Hady Ali , Wafaa Shousha, EL Sayed El Mahdy,andHeba
Mohammad.The association of polymorphicN-Acetyltransferase (NAT-2) with breast
cancer risk in Egyptian women.Arab J.Biochemistry &Molecular Biology,1(1):916,2006.
15-Mohammad AM, Abdel HA, Ahmed AM ,Wael T,Eiman G.Expression of
cyclooxygenase-2 and 12-lipoxygenase in humanbreast cancer and their relation with
HER-2/neu and hormonal receptors: Impact on prognosis and therapy. Indian Journal
of Cancer,43(4):163-168,2006.
16-Abdel Hadi Ali,Mohammad Ali, Wael Yassien, Sabry Sharawy. Reverse
transcriptase –PCR detection of Egyptian breast cancer micrometastasis using
multimarker panel.The Medical Journal Of Cairo University.75(2):333-339,2007.
17-Mohammad AM, Mohammad MS, Attaby FA, Abo-Taleb H. N-acetyltransferase2
gene polymorphism in bladder cancer.Arabe J. Lab. Med.,33(1):83-92,2007.
18- Zeeneldin AA, Mohamed A M, Abdelhady A A, Taha F M, Goda I A, Abodeef W
T. Survival effects of Cyclooxygenase-2 and 12- Lipooxygenase in Egyptian women
with operable breast cancer. Indian journal of cancer .46 (1) :54-60 .2009.
19- Mohammad A . Mohammad, Naglaa R. Ismael, Sabry M. Shaarawy, Mahmoud
M. El-Merzabani. Prognostic value of membrane type1 and 2 matrix
metalloproteinase expression and gelatinase A activity in bladder cancer. Int J Biol
Markers. 25(2) : 69-74. 2010.
20- Mohammad A. Mohammad, Ahmed A. Zeeneldin, Zakaria Y. Abd Elmgeed,
Ebtsam H. Khalil, Said M. Mahdy, Hayat M. Sharada, Sabry M. Sharaawy, Abdel –
Hady A. Aabdel-Wahab. Clinical relevance of cyclooxygenase-2 and matrix
metalloproteinases ( MMP-2 and MT1MMP ) in human breast cancer. Mol Cell
Biochem. 10.1007/s11010-012-1305-z. 2012.
21- Mohammed A Mohammed, Manar F Selem, Mohga S Abdalla, Hayat M Sharada,
Abdel Hahy A Abdel Wahab. Urinary high molecular weight matrix
metalloproteinases as non-invasive biomarker for detection of bladder cancer. BMC
Urology. 13:25. 2013.